<DOC>
	<DOCNO>NCT02744755</DOCNO>
	<brief_summary>Clinical trial compare treatment GP2017 Humira® patient Rheumatoid Arthritis</brief_summary>
	<brief_title>Clinical Trial Compare Treatment With GP2017 Humira® Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description>The purpose study demonstrate similar efficacy safety GP2017 US-licensed Humira® patient moderate severe rheumatoid arthritis ( RA ) inadequate response Disease modify anti-rheumatic drug ( DMARDs ) , include methotrexate ( MTX ) .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>1 . Patients must diagnose RA ≥ 6 month prior screen 2 . Patients must active disease , define DAS28CRP ≥ 3.2 time screen 3 . Patients must CRP level 5mg/l ESR level upper limit normal 4 . Patients must inadequate clinical response MTX 10 25 mg/week 1 . Previous treatment adalimumab , antiTNFα therapy cell deplete agent , e.g . antiCD20 therapy 2 . Women childbearing potential , defined woman physiologically capable become pregnant , unless use highly effective method contraception treatment 3 . Nursing ( lactate ) pregnant woman 4 . History ongoing inflammatory autoimmune disease RA , e.g . mixed connective tissue disease , systemic lupus erythematosus etc . 5 . Systemic corticosteroid &gt; 7.5mg/day within 4 week prior baseline 6 . History presence cancer lymphoproliferative disease successfully completely treat nonmetastatic cutaneous squamous cell basal cell carcinoma and/or localize carcinoma situ cervix and/or remove noninvasive colon polyp , evidence recurrence 7 . History uncontrolled diabetes , unstable ischemic heart disease , congestive heart failure ( New York Heart Association IIIIV ) , active peptic ulcer disease , recent stroke ( within 3 month ) 8 . Subject know immune deficiency , history positive human immunodeficiency virus ( HIV ) status immunocompromised reason 9 . History clinically significant hematologic ( e.g . severe anemia , leucopenia , thrombocytopenia ) , renal liver disease ( e.g . glomerulonephritis , fibrosis , cirrhosis , hepatitis ) 10 . History persistent chronic infection ; recurrent infection active infection 11 . History tuberculosis , presence active tuberculosis , latent tuberculosis detect imaging ( e.g . chest Xray , chest Computerized Tomography ( CT ) scan , Magnetic Resonance Imaging ( MRI ) ) and/ positive QuantiFERONTB Gold test ( QFT ) 12 . History evidence opportunistic infection , e.g . histoplasmosis , listeriosis , legionellosis 13 . Positive serology Hepatitis B ( either HBsAg antiHBc ) Hepatitis C ( positive HCVAb HCVRNA ) indicative previous current infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>